Cargando...
Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma
BACKGROUND: Chordoma is a rare, slow growing and locally aggressive mesenchymal neoplasm with uncommon distant metastases. It is a chemo-resistant disease with surgery and radiotherapy being the mainstay in treatment of localized disease. In advanced disease imatinib has a role. We report a case of...
Gardado en:
| Publicado en: | Clin Sarcoma Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733273/ https://ncbi.nlm.nih.gov/pubmed/33308288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-020-00149-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|